Glimric MP 1mg/500mg/15mg Tablet SR

Overview Glimric MP 1mg/500mg/15mg Tablet SR

Metformin/Pioglitazone/Glimepiride extended-release tablets (1mg/500mg/15mg) offer triple-action blood glucose management. This combination therapy, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, resulting in reduced blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose risks hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Kidney function will be assessed before treatment initiation. Limit alcohol consumption to mitigate potential side effects.

Uses of Glimric MP 1mg/500mg/15mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimric MP 1mg/500mg/15mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimric MP 1mg/500mg/15mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.

Common Side effects of Glimric MP 1mg/500mg/15mg Tablet SR:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Glimric MP 1mg/500mg/15mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glimric MP 1mg/500mg/15mg Extended-Release tablet should be administered with food.

How Glimric MP 1mg/500mg/15mg Tablet SR works:

Glimric MP 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.

What if you forget to take Glimric MP 1mg/500mg/15mg Tablet SR :

Should you forget to take a Glimric MP 1mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.